Woman Diagnosed With Cancer After 2023 Fall
A Baton Rouge resident discovered advanced ovarian cancer and a genetic mutation following a lawnmower accident.
Updated on Sept. 20, 2026 in Cancer
In late summer 2023, 64-year-old Dawn Riviere sustained a fall while mowing the lawn, leading to the discovery of advanced-stage ovarian cancer. Subsequent medical testing revealed she carries the BRCA1 gene mutation.
Why it matters
The diagnosis underscores the critical nature of identifying genetic mutations like BRCA1, which significantly elevate the risk for certain cancers. Riviere's case highlights how incidental medical findings following an injury can lead to life-saving clinical interventions.
Women with the BRCA1 mutation face an ovarian cancer risk of 39% to 58% and a breast cancer risk of 55% to 72%. Medical scans identified a 2.5-centimeter recurrent abdominal mass in Riviere following her initial treatment.
The players
Dawn Riviere
She is a 64-year-old resident of Torbert, Louisiana, who was diagnosed with advanced-stage ovarian cancer.
The details
Following her fall and subsequent abdominal pain, Riviere underwent biopsies in Baton Rouge to confirm her diagnosis. She completed six rounds of chemotherapy in 2024 and surgical procedures to remove both initial tumors and a later recurrent abdominal mass.
Timeline
Late summer 2023: Riviere experienced a fall while mowing the lawn.
2024: Riviere completed six rounds of chemotherapy.
Health Landscape
This case follows the established precedent of BRCA1 genetic mutation screening protocols in identifying high-risk patients. The experience underscores the shift toward integrating genetic testing into standard diagnostic pathways for advanced cancer patients.
Patients may consider requesting genetic testing for mutations like BRCA1 if they have a family history of ovarian or breast cancer. Understanding these genetic markers can allow for proactive risk-reduction measures, such as the preventive hysterectomy undertaken by Riviere's sister.
The takeaway
Early detection of genetic markers can provide family members with the opportunity to take preventative action before disease develops. Those with a family history of cancer are encouraged to consult with healthcare providers about the utility of genetic counseling.
What happens next
Riviere is scheduled to complete her current chemotherapy regimen and will begin maintenance infusion treatment shortly thereafter.
Further reading
Learn more about prevention and treatment in the Cancer section.
Source note: This article includes information reported by NOLA.
